Nemtabrutinib is a medication being studied for its potential to treat various blood cancers. It works by targeting specific proteins in cancer cells, which may help to stop the growth and spread of these cells. The trial aims to determine how safe and tolerable this medication is for patients, as well as to find the most effective dose. Researchers are also looking at how well it works in treating different types of blood cancers, such as chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and others. By participating in this trial, patients may help to advance the understanding of how this medication can be used to treat these serious conditions.

Chronic Lymphocytic Leukemia – Chronic Lymphocytic Leukemia is a type of cancer that affects the blood and bone marrow. It progresses slowly and is characterized by the accumulation of abnormal lymphocytes, a type of white blood cell. Over time, these abnormal cells can crowd out healthy blood cells, leading to symptoms such as fatigue, infections, and swollen lymph nodes. The disease often remains asymptomatic for years before symptoms appear. As it advances, it can affect the body’s ability to fight infections and may cause anemia or bleeding problems.

Small Lymphocytic Lymphoma – Small Lymphocytic Lymphoma is a type of non-Hodgkin lymphoma that primarily affects the lymph nodes. It is closely related to Chronic Lymphocytic Leukemia, with the main difference being the location of the cancer cells. The disease progresses slowly and may not cause symptoms for a long time. When symptoms do occur, they can include swollen lymph nodes, fatigue, and night sweats. The disease can eventually spread to other parts of the body, including the liver and spleen.

Richter’s Transformation – Richter’s Transformation is a condition where Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma transforms into a more aggressive form of lymphoma, usually Diffuse Large B-Cell Lymphoma. This transformation leads to a rapid progression of the disease, with symptoms such as rapidly enlarging lymph nodes, fever, and weight loss. The transformation can occur suddenly and is often associated with a poor response to standard treatments. It represents a significant change in the disease’s behavior and requires different management strategies.

Mantle Cell Lymphoma – Mantle Cell Lymphoma is a rare type of non-Hodgkin lymphoma that arises from B-cells, a type of white blood cell. It typically affects the lymph nodes but can also involve the spleen, bone marrow, and gastrointestinal tract. The disease is characterized by a combination of slow and aggressive growth patterns. Symptoms may include swollen lymph nodes, fever, night sweats, and weight loss. The disease can spread to other parts of the body, complicating its progression.

Marginal Zone Lymphoma – Marginal Zone Lymphoma is a type of slow-growing non-Hodgkin lymphoma that originates from B-cells. It often affects the lymph nodes, spleen, or mucosal-associated lymphoid tissue. The disease progresses slowly, and symptoms may not appear for years. When symptoms do occur, they can include swollen lymph nodes, fatigue, and abdominal discomfort. The disease can spread to other organs over time, affecting their function.

Follicular Lymphoma – Follicular Lymphoma is a common type of indolent non-Hodgkin lymphoma that arises from B-cells. It typically affects the lymph nodes and can spread to the bone marrow and spleen. The disease progresses slowly, often without symptoms for many years. When symptoms develop, they may include painless swollen lymph nodes, fatigue, and night sweats. The disease can transform into a more aggressive form of lymphoma over time.

Waldenström’s Macroglobulinemia – Waldenström’s Macroglobulinemia is a rare type of non-Hodgkin lymphoma characterized by the overproduction of a protein called immunoglobulin M (IgM). This condition affects the bone marrow and can lead to symptoms such as fatigue, bleeding, and vision problems. The disease progresses slowly, and symptoms may not appear for a long time. As it advances, it can cause complications such as anemia and hyperviscosity syndrome, where the blood becomes too thick. The disease can also affect the nervous system and other organs.